Skip to main content
. 2019 Feb 26;63(3):e02262-18. doi: 10.1128/AAC.02262-18

TABLE 1.

Antimicrobial activity of omadacycline tested against the main organisms and organism groups of isolates from all countries combined

Organism or organism group (no. of isolates) No. (cumulative %) of isolates at an MIC (mg/liter) of:
MIC50 (mg/liter) MIC90 (mg/liter)
≤0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 >32
Staphylococcus aureus (689) 1 (0.1) 39 (5.8) 487 (76.5) 117 (93.5) 35 (98.5) 10 (100.0) 0.12 0.25
    Methicillin susceptible (390) 0 (0.0) 23 (5.9) 333 (91.3) 32 (99.5) 2 (100.0) 0.12 0.12
    Methicillin resistant (299) 1 (0.3) 16 (5.7) 154 (57.2) 85 (85.6) 33 (96.7) 10 (100.0) 0.12 0.5
    Tetracycline resistant (317) 17 (5.45) 182 (62.8) 77 (87.1) 32 (97.2) 9 (100.0) 0.12 0.5
    Doxycycline resistant (33) 9 (27.3) 10 (57.6) 10 (87.9) 4 (100.0) 0.25 1
Enterococcus spp. (103) 15 (14.6) 54 (67.0) 28 (94.2) 5 (99.0) 1 (100.0) 0.06 0.12
    Vancomycin nonsusceptible (>4 mg/liter; 13) 2 (15.45) 9 (84.6) 2 (100.0) 0.06 0.12
    Enterococcus faecalis (48) 5 (10.4) 19 (50.0) 18 (87.5) 5 (97.9) 1 (100.0) 0.06 0.25
    Enterococcus faecium (52) 10 (19.2) 32 (80.8) 10 (100.0) 0.06 0.12
Streptococcus pneumoniae (392) 20 (5.1) 233 (64.5) 134 (98.7) 5 (100.0) 0.06 0.12
    Penicillin resistant, oral (≥2 mg/liter; 211) 6 (2.8) 125 (62.1) 77 (98.6) 3 (100.0) 0.06 0.12
    Tetracycline resistant (359) 14 (3.9) 209 (62.1) 131 (98.6) 5 (100.0) 0.12 0.5
    Tigecycline nonsusceptible (36) 2 (5.6) 31 (91.7) 36 (100.0) 0.25 1
Viridans group streptococci (94) 20 (21.3) 53 (77.7) 15 (93.6) 6 (100.0) 0.06 0.12
β-Hemolytic streptococci (166) 0 (0.0) 36 (21.7) 76 (67.5) 38 (90.4) 14 (98.8) 2 (100.0) 0.12 0.25
Enterobacteriaceae (1,041) 0 (0.0) 8 (0.8) 137 (13.9) 357 (48.2) 277 (74.8) 146 (88.9) 47 (93.4) 44 (97.6) 21 (99.6) 4 (100.00) 2 8
Escherichia coli (425) 0 (0.0) 7 (1.6) 124 (30.8) 180 (73.2) 86 (93.4) 23 (98.8) 3 (99.5) 2 (100.0) 1 2
    ESBL phenotype (249) 0 (0.0) 5 (2.0) 70 (30.1) 104 (71.9) 50 (92.0) 15 (98.0) 3 (99.2) 2 (100.0) 1 2
Klebsiella pneumoniae (307) 0 (0.0) 1 (0.3) 11 (3.9) 114 (41.0) 91 (70.7) 54 (88.3) 20 (94.8) 12 (98.7) 3 (99.7) 1 (100.0) 2 8
    ESBL phenotype (134) 0 (0.0) 2 (1.5) 33 (26.1) 37 (53.7) 37 (81.3) 14 (91.8) 9 (98.5) 1 (99.3) 1 (100.0) 2 8
Klebsiella oxytoca (16) 0 (0.0) 10 (62.5) 2 (75.0) 3 (93.8) 1 (100.0) 1 4
Enterobacter cloacae species complex (110) 0 (0.0) 23 (20.9) 59 (74.5) 18 (90.9) 5 (95.5) 3 (98.2) 2 (100.0) 2 4
    Ceftazidime nonsusceptible (>4 mg/liter; 52) 0 (0.0) 6 (11.5) 26 (61.5) 12 (84.6) 5 (94.2) 2 (98.1) 1 (100.0) 2 8
Serratia marcescens (46) 0 (0.0) 12 (26.1) 33 (97.8) 1 (100.0) 4 4
Acinetobacter baumannii (225) 0 (0.0) 2 (0.9) 24 (11.6) 6 (14.2) 1 (14.7) 9 (18.7) 90 (58.7) 81 (94.7) 7 (97.8) 4 (99.6) 1 (100.0) 4 8
Pseudomonas aeruginosa (300) 0 (0.0) 4 (1.3) 2 (2.0) 20 (8.7) 121 (49.0) 153 (100.0) >32 >32
Haemophilus influenzae (181) 0 (0.0) 12 (6.6) 88 (55.2) 69 (93.4) 12 (100.0) 0.5 1
    β-Lactamase positive (69) 0 (0.0) 35 (50.7) 29 (92.8) 5 (100.0) 0.5 1
Haemophilus parainfluenzae (7) 0 (0.0) 1 (14.3) 6 (100.0) 1
Moraxella catarrhalis (75) 57 (76.0) 18 (100.0) ≤0.12 0.25